MURUGAPPAN M, BABU B, SHANKAR V, YUSUF M, JAWAHAR N. ROLE OF FDA 483 OBSERVATIONS IN QUALITY MANAGEMENT SYSTEMS: ENHANCING COMPLIANCE AND RISK MANAGEMENT. Asian J Pharm Clin Res [Internet]. 2025 Apr. 7 [cited 2025 Dec. 6];18(4):44-51. Available from: https://www.journals.innovareacademics.in/index.php/ajpcr/article/view/54004